| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/28/2004 | CN1159058C Medicine for treating cholecystopathy |
| 07/28/2004 | CN1159057C Medicine for treating hepatitis, and preparing process thereof |
| 07/28/2004 | CN1159054C Tongfuzhixie preparation |
| 07/28/2004 | CN1159052C Lozenge for removing oral abnormal smell and its preparation method |
| 07/28/2004 | CN1159049C Medicine for curing constipation and its preparing method |
| 07/28/2004 | CN1159046C Health-care products for tender and deficient in energy |
| 07/28/2004 | CN1159045C Medicine for preventing and treating animal's gastrointestinal tract diseases |
| 07/28/2004 | CN1159042C Application of medicine preparaed from spearmint for treating chronic and ulcerative colitis |
| 07/28/2004 | CN1159040C Chinese medicine for curing gastropathy and its preparation method |
| 07/28/2004 | CN1159027C Medicine for curing liver disease |
| 07/28/2004 | CN1159020C Production method of gastric ulcer quickly-healing prepartion |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158993C Thermal stabilized antiacid and deaired suspensoid agent |
| 07/27/2004 | US6768019 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1h-naphthalene-2 -one oxime |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/24/2004 | WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004060914A1 A human liver regeneration associated protein and the use of it |
| 07/22/2004 | WO2004060893A1 Pyrrolopyridine potassium channel openers |
| 07/22/2004 | WO2004060891A1 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060402A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier |
| 07/22/2004 | WO2004060401A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | WO2004060377A1 Derivatives of prostaglandins for treating abdominal discomfort |
| 07/22/2004 | WO2004060372A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer |
| 07/22/2004 | WO2004060263A2 Magnesium salt of imidazole derivative |
| 07/22/2004 | WO2004060081A1 A method of improving nutrient utilisation by a mammal and a composition for use therein |
| 07/22/2004 | WO2004041291A9 High affinity receptors for helicobacter pylori and use thereof |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2004037187A8 Metal-containing materials, compositions and methods |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142967 Pain maintenance |
| 07/22/2004 | US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 07/22/2004 | US20040142935 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142921 treatment and/or prevention of type 2 diabetes and associated metabolic syndrome |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142907 for the preventive or curative treatment of hepatocellular deficiency |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142354 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142032 treating of ulcers and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome; free of (+) isomer; inhibits H+,K+-ATPase with out the adverse effects seen upon administration of racemic pantoprazole. |
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | US20040141963 Medical adsorbent and process for production of the same |
| 07/22/2004 | US20040141949 Treatment of mucositis |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2708895A1 Compositions, methods and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | CA2510051A1 Derivatives of prostaglandins for treating abdominal discomfort |
| 07/22/2004 | CA2507971A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438407A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438309A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 07/21/2004 | EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438290A1 Cyclohept b!indole derivatives as spla2 inhibitors |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438055A1 D-tagatose as an anti-biofilm agent |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |